EMEA-001912-PIP02-16-M02

Key facts

Active substance
Angiotensin II (LJPC-501)
Therapeutic area
Cardiovascular diseases
Decision number
P/0159/2019
PIP number
EMEA-001912-PIP02-16-M02
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of catecholamine-resistant hypotension associated with distributive shock
Route(s) of administration
Intravenous use
Contact for public enquiries
La Jolla Pharmaceutical II B.V.
Tel. +1 6502083191
E-mail: gtidmarsh@ljpc.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating